<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>1. Telemedicine/medication program for opioid use disorder is one of the only tools we have to combat the poisoning of individuals killing the youth and devastating the lives of families. by </title>
      <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r</link>
      <description></description>
      <language>en-us</language>
      <pubDate>2024-05-24 01:56:27 UTC</pubDate>
      <lastBuildDate>2024-05-24 05:08:27 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet.net/icons/png/1f497.png</url>
      </image>
      <item>
         <title>10. APA</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005850072</link>
         <description><![CDATA[<p>&nbsp;</p><p>ABC News. (2024, January 11). <em>Watch Jelly Roll deliver testimony at Senate hearing on fentanyl bill. Video</em>. YouTube. <a rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=M_NULoJyNAw">https://www.youtube.com/watch?v=M_NULoJyNAw</a></p><p>&nbsp;</p><p>McKellar, M. S., Des Marais, A. C., Chen, H., Choi, Y., Lilly, R., Ayers, D., Bennett, J., Kestner, L., Perry, B., Poley, S., Corneli, A., Meade, C. S., &amp; Sachdeva, N. (2024). Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study. <em>Harm Reduction Journal</em>, <em>21</em>(1), NA. <a rel="noopener noreferrer nofollow" href="http://dx.doi.org/10.1186/s12954-024-00983-2">http://dx.doi.org/10.1186/s12954-024-00983-2</a></p><p><br/></p><p>Wang, J., Claman, A., Singh, S., Sidelnik, S. A., &amp; Arshed, A. (2023). Best Practices in Substance Use Disorders to Achieve Treatment Equity in Consultation-Liaison Psychiatry. <em>Psychiatric Annals</em>, <em>53</em>(1), 23+. <a rel="noopener noreferrer nofollow" href="http://dx.doi.org/10.3928/00485713-20230103-04">http://dx.doi.org/10.3928/00485713-20230103-04</a></p>]]></description>
         <enclosure url="" />
         <pubDate>2024-05-24 03:08:21 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005850072</guid>
      </item>
      <item>
         <title></title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005858419</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/2503332695/cd524d691d9d325f144c495997f76318/image.png" />
         <pubDate>2024-05-24 03:14:02 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005858419</guid>
      </item>
      <item>
         <title>3. Date Published</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005862259</link>
         <description><![CDATA[<p>June 2019</p>]]></description>
         <enclosure url="" />
         <pubDate>2024-05-24 03:16:47 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005862259</guid>
      </item>
      <item>
         <title>4. Summary of current innovation</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005877842</link>
         <description><![CDATA[<p>A telemedicine-based program to provide PWID with medication for opioid use disorder (MOUD) with buprenorphine/naloxone (bup/nx) and oral pre-exposure prophylaxis (PrEP) in North Carolina</p>]]></description>
         <enclosure url="" />
         <pubDate>2024-05-24 03:28:17 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005877842</guid>
      </item>
      <item>
         <title>2. BioMed Central Ltd.</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005892975</link>
         <description><![CDATA[<p><strong>McKellar, M. S., Des Marais, A. C., Chen, H., Choi, Y., Lilly, R., Ayers, D., Bennett, J., Kestner, L., Perry, B., Poley, S., Corneli, A., Meade, C. S., &amp; Sachdeva, N. (2024)</strong></p>]]></description>
         <enclosure url="" />
         <pubDate>2024-05-24 03:40:48 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005892975</guid>
      </item>
      <item>
         <title>5. We MUST INNOVATE Treatment options</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005896648</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.youtube.com/watch?v=M_NULoJyNAw" />
         <pubDate>2024-05-24 03:44:08 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005896648</guid>
      </item>
      <item>
         <title>6. Pros</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005907848</link>
         <description><![CDATA[<p>Treatment that can be mass produced </p><p>convent for patients whom already have very hard lives</p><p>SAVES LIVES</p><p>private</p><p>less coordination </p><p><br/></p><p><br/></p>]]></description>
         <enclosure url="" />
         <pubDate>2024-05-24 03:54:09 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005907848</guid>
      </item>
      <item>
         <title>7. CONS</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005908458</link>
         <description><![CDATA[<p>Requires a device although solutions to this are many</p><p><br/></p><p>Needs total funding (Substance abuse patients often have no income)</p><p><br/></p><p>Does require public education to be produced on a large scale</p>]]></description>
         <enclosure url="" />
         <pubDate>2024-05-24 03:54:50 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005908458</guid>
      </item>
      <item>
         <title>8. Opinion and Rationale</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005914137</link>
         <description><![CDATA[<p>"Virtual/telehealth appointments extend access to those with limited mobility or no nearby treatment options, and those who feel stigmatized coming in person," (Wang, J., Claman, A., Singh, S., Sidelnik, S. A., &amp; Arshed, A. (2023).</p>]]></description>
         <enclosure url="" />
         <pubDate>2024-05-24 04:00:13 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005914137</guid>
      </item>
      <item>
         <title>9. My 5 and My Team</title>
         <author>HolleyRay</author>
         <link>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005923050</link>
         <description><![CDATA[<ol><li><p>POSITIVITY</p></li><li><p>FUTURISTIC</p></li><li><p>EMPATHY</p></li><li><p>IDEATION</p></li><li><p>CONNECTEDNESS</p></li></ol><p>My positivity has the ability to help others become enthusiastic and momentum. As for my other strengths I am good at connecting people, having a vision, loving people where they are at, and believing in innovating the future to save lives. </p><p>Sheila - Strategic-To execute we need someone who can problem solve with thought</p><p>Emily – Empathy- Having another person who cares and can help set the tone of cause and compassion</p><p>Amelia – Adaptability-The ability to adapt and overcome can be a game saving trait when everyone else is stuck.</p><p>Carter – Communication-The devil is in the details and communication is vital.</p><p>Alice – Achiever- Alice will not quit. That is also infectious. Hard work inspires others to also work hard in the face of uncertainty. </p><p><br/></p>]]></description>
         <enclosure url="" />
         <pubDate>2024-05-24 04:09:18 UTC</pubDate>
         <guid>https://padlet.com/HolleyRay/77nxqr8oqlnl9l0r/wish/3005923050</guid>
      </item>
   </channel>
</rss>
